2019 ACR适宜性标准:黄疸

2019-05-16 美国放射学会 J Am Coll Radiol. 2019 May;16(5S):S126-S140.

2019年5月,美国放射学会(ACR)发布了黄疸的影像学检查标准指南。多种病因可以导致黄疸,这似的黄疸患者的影像学检查充满挑战。用于评估黄疸患者的所有影像学检查方法包括腹部超声,CT,磁共振胰胆管造影,内镜逆行胰胆管造影以及内镜下超声检查。本文主要针对黄疸患者适宜性影像学检查提供指导建议。

中文标题:

2019 ACR适宜性标准:黄疸

英文标题:

ACR Appropriateness Criteria® Jaundice.

发布机构:

美国放射学会

发布日期:

2019-05-16

简要介绍:

2019年5月,美国放射学会(ACR)发布了黄疸的影像学检查标准指南。多种病因可以导致黄疸,这似的黄疸患者的影像学检查充满挑战。用于评估黄疸患者的所有影像学检查方法包括腹部超声,CT,磁共振胰胆管造影,内镜逆行胰胆管造影以及内镜下超声检查。本文主要针对黄疸患者适宜性影像学检查提供指导建议。 

拓展指南:黄疸相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ACR适宜性标准:黄疸)] GetToolGuiderByIdResponse(projectId=1, id=b21531c001ea9973, title=2019 ACR适宜性标准:黄疸, enTitle=ACR Appropriateness Criteria® Jaundice., guiderFrom=J Am Coll Radiol. 2019 May;16(5S):S126-S140., authorId=null, author=, summary=2019年5月,美国放射学会(ACR)发布了黄疸的影像学检查标准指南。多种病因可以导致黄疸,这似的黄疸患者的影像学检查充满挑战。用于评估黄疸患者的所有影像学检查方法包括腹部超声,CT,磁共振胰胆管造影,内镜逆行胰胆管造影以及内镜下超声检查。本文主要针对黄疸患者适宜性影像学检查提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=191, associationName=美国放射学会, associationIntro=美国放射学会(American College of Radiology)拥有会员超过34,000名,包括美国放射医师,放射肿瘤学家,物理学家介入医师及核医学医师。其指南按放射检查的方法分类,共十组,每组下包括指南十余篇。同时向NGC提供了近200篇指南。学会拥有《ACR Bulletin》及《JACR》两本官方期刊。, copyright=0, guiderPublishedTime=Thu May 16 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年5月,美国放射学会(ACR)发布了黄疸的影像学检查标准指南。多种病因可以导致黄疸,这似的黄疸患者的影像学检查充满挑战。用于评估黄疸患者的所有影像学检查方法包括腹部超声,CT,磁共振胰胆管造影,内镜逆行胰胆管造影以及内镜下超声检查。本文主要针对黄疸患者适宜性影像学检查提供指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>黄疸</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=d4b491c001693935" title="梗阻性黄疸经皮肝穿刺胆道引流及支架植入术专家共识(2018)" target=_blank>梗阻性黄疸经皮肝穿刺胆道引流及支架植入术专家共识(2018)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=3e1571c001536a9e" title="2017 昆士兰产科与新生儿临床指南:新生儿黄疸" target=_blank>2017 昆士兰产科与新生儿临床指南:新生儿黄疸</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5118d1c00136a97a" title="28天以下的新生儿黄疸:NICE指南2016(CG98)" target=_blank>28天以下的新生儿黄疸:NICE指南2016(CG98)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a244d1c0012a06c2" title="2016 NASPGHAN/ESPGHAN联合建议:婴幼儿胆汁淤积性黄疸的评估指南" target=_blank>2016 NASPGHAN/ESPGHAN联合建议:婴幼儿胆汁淤积性黄疸的评估指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c39d21c00120982c" title="2016NICE:出生28天内新生儿黄疸指南更新" target=_blank>2016NICE:出生28天内新生儿黄疸指南更新</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E9%BB%84%E7%96%B8" target=_blank>有关黄疸更多指南</a></ul>, tagList=[TagDto(tagId=879, tagName=黄疸), TagDto(tagId=3844, tagName=ACR)], categoryList=[CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14326, appHits=455, showAppHits=5, pcHits=12314, showPcHits=2338, likes=64, shares=5, comments=4, approvalStatus=1, publishedTime=Thu Jun 20 22:09:32 CST 2019, publishedTimeString=2019-05-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jun 20 22:09:32 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 15:43:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ACR适宜性标准:黄疸)])
2019 ACR适宜性标准:黄疸
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=949367, encodeId=a24894936eee, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c35470718, createdName=ms5000001979665331, createdTime=Thu Mar 18 22:21:27 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370610, encodeId=45ca3e0610d0, content=非常受用,感谢梅斯医学这个平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d2b5086486, createdName=AQ兰, createdTime=Thu Aug 01 16:38:53 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368112, encodeId=33903681124e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa32365525, createdName=122e052cm96暂无昵称, createdTime=Fri Jun 21 13:03:58 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368090, encodeId=f5d036809016, content=学习了,谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=d41c2055892, createdName=184****9840, createdTime=Fri Jun 21 06:40:47 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
    2021-03-18 ms5000001979665331

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=949367, encodeId=a24894936eee, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c35470718, createdName=ms5000001979665331, createdTime=Thu Mar 18 22:21:27 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370610, encodeId=45ca3e0610d0, content=非常受用,感谢梅斯医学这个平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d2b5086486, createdName=AQ兰, createdTime=Thu Aug 01 16:38:53 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368112, encodeId=33903681124e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa32365525, createdName=122e052cm96暂无昵称, createdTime=Fri Jun 21 13:03:58 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368090, encodeId=f5d036809016, content=学习了,谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=d41c2055892, createdName=184****9840, createdTime=Fri Jun 21 06:40:47 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
    2019-08-01 AQ兰

    非常受用,感谢梅斯医学这个平台

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=949367, encodeId=a24894936eee, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c35470718, createdName=ms5000001979665331, createdTime=Thu Mar 18 22:21:27 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370610, encodeId=45ca3e0610d0, content=非常受用,感谢梅斯医学这个平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d2b5086486, createdName=AQ兰, createdTime=Thu Aug 01 16:38:53 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368112, encodeId=33903681124e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa32365525, createdName=122e052cm96暂无昵称, createdTime=Fri Jun 21 13:03:58 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368090, encodeId=f5d036809016, content=学习了,谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=d41c2055892, createdName=184****9840, createdTime=Fri Jun 21 06:40:47 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
    2019-06-21 122e052cm96暂无昵称

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=949367, encodeId=a24894936eee, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c35470718, createdName=ms5000001979665331, createdTime=Thu Mar 18 22:21:27 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370610, encodeId=45ca3e0610d0, content=非常受用,感谢梅斯医学这个平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d2b5086486, createdName=AQ兰, createdTime=Thu Aug 01 16:38:53 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368112, encodeId=33903681124e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa32365525, createdName=122e052cm96暂无昵称, createdTime=Fri Jun 21 13:03:58 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368090, encodeId=f5d036809016, content=学习了,谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=d41c2055892, createdName=184****9840, createdTime=Fri Jun 21 06:40:47 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
    2019-06-21 184****9840

    学习了,谢谢分享。

    0